Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-0851
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody ; day:17 ; month:8 ; year:2017 ; pages:1-12
Cancer immunology immunotherapy ; (17.8.2017), 1-12

Schlagwort
Krebs
Onkologie

Urheber
Muthumani, Kar
Beteiligte Personen und Organisationen
Marnin, Liron
Kudchodkar, Sagar B.
Perales-Puchalt, Alfredo
Choi, Hyeree
Agarwal, Sangya
Scott, Veronica L.
Reuschel, Emma L.
Zaidi, Faraz I.
Duperret, Elizabeth K.
Wise, Megan C.
Kraynyak, Kimberly A.
Ugen, Kenneth. E.
Sardesai, Niranjan Y.
Joseph Kim, J.
Weiner, David B.
SpringerLink (Online service)

DOI
10.1007/s00262-017-2042-7
URN
urn:nbn:de:1111-201710309097
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:25 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Muthumani, Kar
  • Marnin, Liron
  • Kudchodkar, Sagar B.
  • Perales-Puchalt, Alfredo
  • Choi, Hyeree
  • Agarwal, Sangya
  • Scott, Veronica L.
  • Reuschel, Emma L.
  • Zaidi, Faraz I.
  • Duperret, Elizabeth K.
  • Wise, Megan C.
  • Kraynyak, Kimberly A.
  • Ugen, Kenneth. E.
  • Sardesai, Niranjan Y.
  • Joseph Kim, J.
  • Weiner, David B.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB

Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB

Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression

Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression

Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy

Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer

Monoclonal antibody therapy

Monoclonal antibody therapy

Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres

Hochschulschrift

Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres

Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes

Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes

Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection

Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection

Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen

Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen

Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer

Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer

A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy

A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy

CpG-DNA : a potential adjuvant in prostate cancer immunotherapy

Hochschulschrift

CpG-DNA : a potential adjuvant in prostate cancer immunotherapy

Verbundene Objekte